IL33 and Alzheimer disease: In addition, astrocytic Ca2+ activity [187], connexin 30 and 43 levels [188], and IL-33 signaling [189] are all impaired in AD, and restoration of IL-33 function has been shown to reverse cognitive deficits [190].